Network Ad
Interested in this space? Reach 36 niche communities. Advertise
Loading...
0

USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity.

Be respectful and constructive. Comments are moderated.

No comments yet.